Endothelial Cells: Not Just a Cellophane Wrapper

Archives of Internal Medicine

Volumn 147, Issue 3, 1987, Pages 569-573

  Kaiser, Lana ^a   Sparks, Harvey V ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; BRADYKININ; PROSTAGLANDIN;

CARDIOVASCULAR SYSTEM; ENDOTHELIUM CELL; ETIOLOGY; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADENOSINE; ANGIOTENSIN II; ANIMAL; BLOOD PLATELETS; BRADYKININ; DOGS; ENDOTHELIUM; HUMAN; PROSTAGLANDINS; SEROTONIN; SUPPORT, U.S. GOV'T, P.H.S.; VASODILATION;

EID: 0023132041     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1987.00370030173034     Document Type: Article

References (34)

1. 1. Florey HW: The endothelial cell. Br Med J 1966;2:487-489.
2. 2. Zweifach BW: Integrity of vascular endothelium. Adv Microcirc 1980;9:206-225.
3. 3. Stemerman MB, Colton C, Morell E: Perturbations of the endothelium, in Spaet TH (ed): Progress in Hemostasis and Thrombosis. New York, Grune & Stratton, 1984, pp 289-324.
4. 4. Shepro D, D’Amore PA: Endothelial cell metabolism. Adv Microcirc 1980;9:161-205.
5. 5. Gimbrone MA: Vascular endothelium and atherosclerosis, in Moore S (ed): Vascular Injury and Atherosclerosis. New York, Marcel Dekker Inc, 1981, pp 25-52.
6. 6. Fishman AP, Pietra GG: Handling of bioactive materials by the lung. N Engl J Med 1974;219:953-959.
7. 7. Pearson JD, Hellewell PG, Gordon JL: Adenosine uptake and adenine nucleotide metabolism by vascular endothelium, in Berne RM, Rall TW, Rubio R (eds): Regulatory Function of Adenosine. Dordrecht, the Netherlands, Martinus Nijhoff Publishers, 1983, pp 333-345.
8. 8. Ryan JW, Ryan US: Endothelial metabolism, in Effros RM, Schmid-Schonbein H, Ditzel J (eds): Microcirculation: Current Physiologic, Medical, and Surgical Concepts. Orlando, Fla, Academic Press Inc, 1981, pp 147-169.
9. 9. Simionescu M, Simionescu N, Palade G: Biochemically differentiated microdomains of the cell surface of capillary endothelium, in Fishman AP (ed): Endothelium. New York, New York Academy of Sciences, 1982, pp 9-24.
10. 10. Douglas WW: Histamine and 5-hydroxytryptamine (serotonin) and their antagonists, in Goodman-Gilman A, Goodman LS, Rall TW, et al (eds): The Pharmacological Basis of Therapeutics. New York, Macmillan Publishing Co Inc, 1985, pp 605-638.
11. 11. Gillis CN, Greene NM, Cronau LH, et al: Pulmonary extraction of 5-hydroxy-tryptamine and norepinephrine before and after cardiopulmonary bypass in man. Circ Res 1972;30:666-674.
12. 12. Catravas JD: Removal of adenosine from the rabbit pulmonary circulation, in vivo and in vitro. Circ Res 1984;54:603-611.
13. 13. Douglas WW: Polypeptides: Angiotensin, plasma kinins and others, in Goodman-Gilman A, Goodman LS, Rall TW, et al (eds): The Pharmacological Basis of Therapeutics. New York, Macmillan Publishing Co Inc, 1985, pp 639-659.
14. 14. Weksler BB, Eldor A, Falcone D, et al: Prostaglandins and vascular endothelium, in Herman AG, Vanhoutte PM, Denolin H, et al (eds): Cardiovascular Pharmacology of the Prostaglandins. New York, Raven Press, 1982, pp 137-148.
15. 15. Moncada S, Gryglewski R, Bunting S, et al: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976;263;663-665.
16. 16. Moncada S, Flower RJ, Vane JR: Prostaglandins, prostacyclin, thromboxane A2, and leukotrienes, in Goodman-Gilman A, Goodman LS, Rall TW, et al (eds): The Pharmacological Basis of Therapeutics. New York, Macmillan Publishing Co Inc, 1985, pp 660-672.
17. 17. Furchgott RF: Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-573.
18. 18. Furchgott RF: The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 1984;24:175-197.
19. 19. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288: 373-376.
20. 20. Rapoport RM, Murad F: Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: Role of cyclic GMP. J Cyclic Nucleotide Protein Phosphor Res 1983;9:281-296.
21. 21. Martin W, Villani GM, Jothianandan D, et al: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232:708-716.
22. 22. Vanhoutte PM: Vasodilator and vasoconstrictor signals generated by the endothelium, in Hunyor S, Ludbrook J, Shaw J, et al (eds): The Peripheral Circulation. New York, Elsevier Science Publishing Co Inc, 1984, pp 3-8.
23. 23. Ignarro LJ, Kadowitz PJ: The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 1985;25:171-191.
24. 24. Kaiser L, Hull SS, Sparks HV: Methylene blue and ETYA block flow dependent dilation in canine femoral artery. Am J Physiol 1986;250: H974-H981.
25. 25. Kaiser L, Sparks HV: Mediation of flow-dependent arterial dilation by endothelial cells. Circ Shock 1986;18:109-114.
26. 26. Hull SS, Kaiser L, Jaffe MD, et al: Endothelium dependent flow induced dilation of canine femoral and saphenous arteries. Blood Vessels, 1986;23:183-189.
27. 27. Pohl U, Holtz J, Busse R, et al: Crucial role of endothelium in the vasodilator responses to flow in vivo. Hypertension 1986;8:37-44.
28. 28. Holtz J, Forstermann U, Pohl U, et al: Flow-dependent, endothelium-mediated dilation of epicardial coronary arteries in conscious dogs: Effects of cyclooxygenase inhibition. J Cardiovasc Pharmacol 1984;6:1161-1169.
29. 29. Lie M, Sejersted DM, Kiil F: Local regulation of vascular cross section during changes in femoral arterial blood flow in dogs. Circ Res 1970;27:727-737.
30. 30. Cohen RA, Shepherd JT, Vanhoutte PM: 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol 1983;245:H1077-H1080.
31. 31. Cohen RA, Shepherd JT, Vanhoutte PM: Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science 1983;221:273-274.
32. 32. Shepherd JT, Vanhoutte PM: Spasm of the coronary arteries: Cause and consequences (the scientist’s viewpoint). Mayo Clin Proc 1985;60:33-46.
33. 33. Lamping KG, Marcus ML, Dole WP: Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res 1985;57:46-54.
34. 34. Habib JB, Bossaller C, Wells S, et al: Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res 1986;58:305-309.